
Alermont Fx Tab
SAAN LAB LLP - tablet - 10 S
Standard delivery
Distributor inventory | Tablet
Voglibose 0.2 mg
Type 2 diabetes mellitus (post‑prandial/high after-meal blood glucose control), used along with diet, exercise and/or other antidiabetic medicines
Voglibose is an alpha‑glucosidase inhibitor that delays digestion and absorption of carbohydrates in the intestine. This reduces the rise in blood glucose after meals and helps improve overall glycaemic control.
Tablet for oral use. Usually taken just before the start of each main meal (or with the first bite of food) as prescribed. If a meal is skipped, skip the dose. Follow diet/exercise advice and monitor blood glucose.
Common side effects of Volibose 0.2 Tab may include:

SAAN LAB LLP - tablet - 10 S
Standard delivery
SAAN LAB LLP - tablet - 10 S
Standard delivery

SAAN LAB LLP - tablet - 10 S
Standard delivery

SAAN LAB LLP - capsule - 10 S
Standard delivery

SAAN LAB LLP - capsule - 10 S
Standard delivery

SAAN LAB LLP - tablet - 10 S
Standard delivery

SAAN LAB LLP - tablet - 10 S
Standard delivery
SAAN LAB LLP - tablet - 10 S
Standard delivery
For type 2 diabetes only; not for diabetic ketoacidosis or type 1 diabetes. Use with caution in patients with inflammatory bowel disease, intestinal obstruction/ulceration, chronic intestinal diseases, severe renal impairment, or liver disease. Risk of hypoglycaemia increases when combined with insulin or sulfonylureas—treat low sugar with glucose (dextrose) rather than sucrose/table sugar. Monitor blood glucose and, if advised, liver enzymes.